Posted in | News | Coatings and Thin Films | Business | Materials Research

Ferro to Divest Powder Coating Business

Aug 6 2002

Ferro Corp. have just signed a definitive agreement to sell their powder coatings business for $160 million. The divestiture will consist of two transactions which will see Akzo Nobel acquire operations in the Americas and Asia Pacific while Rohm and Haas will acquire European operations.

The operations that will go to Akzo Nobel consist of two manufacturing facilities and a research and development facility in the USA as well as two facilities in the Asian region. Rohm and Haas will likewise acquire three manufacturing operations across Europe.

The divestitures are consistent with Ferro’s long term strategy which did not include the powder coatings divisions. They will have better opportunity to grow under the new ownership.

For more information on coatings, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback